These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18394354)

  • 1. Picking a PPI: it comes down to cost.
    Wigle PR; Hein B; Ellis R; Austin O; Kiesler J; Gait KA
    J Fam Pract; 2008 Apr; 57(4):231-6. PubMed ID: 18394354
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy?
    Barkun AN
    Gastrointest Endosc; 2008 Jun; 67(7):1064-6. PubMed ID: 18513549
    [No Abstract]   [Full Text] [Related]  

  • 6. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users.
    Katz MH
    Arch Intern Med; 2010 May; 170(9):747-8. PubMed ID: 20458079
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate proton pump inhibitor use among older adults: a retrospective chart review.
    George CJ; Korc B; Ross JS
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):249-54. PubMed ID: 19161927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clopidogrel plus proton pump inhibitor: is infarct risk increased? (interview by Dr. Thomas Meissner)].
    Petersen KU
    MMW Fortschr Med; 2009 Jun; 151(23):7. PubMed ID: 19591342
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing alternatives to prior authorization.
    Manag Care; 2010 Jan; 19(1):50. PubMed ID: 20131644
    [No Abstract]   [Full Text] [Related]  

  • 13. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events.
    Elias E; Targownik LE
    Drugs; 2019 May; 79(7):715-731. PubMed ID: 30972661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population.
    Doan QV; Lange SM; Elfant A; Aguilar D; Reyes E; Lynn RB; Dubois RW
    J Med Econ; 2008; 11(1):23-40. PubMed ID: 19450108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In process].
    Storr M
    Med Monatsschr Pharm; 2016 Sep; 39(9):391-5. PubMed ID: 29956514
    [No Abstract]   [Full Text] [Related]  

  • 16. Another PPI precaution.
    Johns Hopkins Med Lett Health After 50; 2014 Apr; 26(2):8. PubMed ID: 24873000
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
    Inotai A; Mészáros A
    Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel: with or without a proton pump inhibitor?
    Zarowitz BJ
    Geriatr Nurs; 2009; 30(3):188-92. PubMed ID: 19520229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.